Position in JNJ
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,224,897
+$234,915 QoQ
Shares Held
4,823
+19.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#2,799
of 4,664 holders
Holding Since
Mar 2021
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Johnson Financial Group, LLC holds $7,394,397 across 9 Drug Manufacturers - General names. JNJ ranks #3 (16.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
6,650 | $1,673,406 | |
| 2 | LLY |
ELI LILLY & Co
|
1,147 | $1,375,746 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
4,823 | $1,224,897 | |
| 4 | MRK |
Merck & Co., Inc.
|
8,613 | $1,106,770 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
6,967 | $880,210 | |
| 6 | AMGN |
Amgen Inc
|
1,188 | $430,198 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
4,210 | $242,580 | |
| 8 | SNY |
Sanofi
|
5,501 | $234,672 |
All Filings in JNJ
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,224,897 | 4,823 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $989,982 | 4,050 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $292,627 | 1,414 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $231,775 | 1,250 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $300,306 | 1,966 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $332,343 | 2,004 | Shares | Sole | 2025-05-12 | |
| 2021-12-31 | $359,075 | 2,099 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $561,858 | 3,479 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $697,344 | 4,233 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $395,261 | 2,405 | Shares | Sole | 2021-05-12 | |
| No filing history on record for this holder in this stock. | ||||||